Detalhe da pesquisa
1.
Relevance of body mass index as a predictor of systemic therapy outcomes in metastatic melanoma: analysis of the MelBase French cohort dataâ.
Ann Oncol
; 32(4): 542-551, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33385520
2.
The combination of ipilimumab and nivolumab is still not reimbursed for BRAF-mutated melanoma patients in France: An unacceptable medical situation that raises ethical concerns.
Ann Dermatol Venereol
; 151(1): 103243, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38325268
3.
Sorafenib in metastatic uveal melanoma: efficacy, toxicity and health-related quality of life in a multicentre phase II study.
Br J Cancer
; 115(1): 20-4, 2016 Jun 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-27253171
4.
Merkel cell carcinoma: value of sentinel lymph-node status and adjuvant radiation therapy.
Ann Oncol
; 27(5): 914-9, 2016 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-26811346
5.
Prognostic and predictive values of oncogenic BRAF, NRAS, c-KIT and MITF in cutaneous and mucous melanoma.
J Eur Acad Dermatol Venereol
; 29(8): 1530-8, 2015 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-25623140
6.
Cutaneous melanoma in patients treated with tumour necrosis factor inhibitors: a retrospective series of 15 patients.
J Eur Acad Dermatol Venereol
; 28(11): 1540-4, 2014 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-24329560
7.
Inequality factors in access to early-phase clinical trials in oncology in France: results of the EGALICAN-2 study.
ESMO Open
; 8(4): 101610, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37536254
8.
Access to early-phase clinical trials in older patients with cancer in France: the EGALICAN-2 study.
ESMO Open
; 7(3): 100468, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35533427
9.
[Items that justify a day-care hospital stay for the management of skin cancer. Guidelines from the Oncodermatology Group of the Société Française de Dermatologie]. / Critères permettant la validation d'un séjour en hôpital de jour d'un malade pris en charge pour un cancer cutané. Recommandations du Groupe de cancérologie de la Société française de dermatologie.
Ann Dermatol Venereol
; 143(8-9): 559-61, 2016.
Artigo
em Francês
| MEDLINE | ID: mdl-27364897
10.
[Merkel cell carcinoma: outcome and role of radiotherapy]. / Carcinome à cellules de Merkel : prise en charge et place de la radiothérapie.
Cancer Radiother
; 12(5): 352-9, 2008 Sep.
Artigo
em Francês
| MEDLINE | ID: mdl-18511325
11.
Male breast cancer and the androgen receptor gene.
Nat Genet
; 5(2): 109-10, 1993 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-8252034
12.
Malignant melanoma of soft parts. A "non plastic surgeon's land"?
Ann Chir Plast Esthet
; 53(4): 361-4, 2008 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-17602816
13.
Update of survival and cost of metastatic melanoma with new drugs: Estimations from the MelBase cohort.
Eur J Cancer
; 105: 33-40, 2018 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-30384014
14.
Leiomyosarcoma of the inferior vena cava.
J Visc Surg
; 153(3): 161-5, 2016 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-26711879
15.
Safety and immunogenicity of the PRAME cancer immunotherapeutic in metastatic melanoma: results of a phase I dose escalation study.
ESMO Open
; 1(4): e000068, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-27843625
16.
Treatment of patients with metastatic renal carcinoma with a combination of subcutaneous interleukin-2 and interferon alfa with or without fluorouracil. Groupe Français d'Immunothérapie, Fédération Nationale des Centres de Lutte Contre le Cancer.
J Clin Oncol
; 18(24): 4009-15, 2000 Dec 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-11118461
17.
Subcutaneous interleukin-2, interferon alfa-2a, and continuous infusion of fluorouracil in metastatic renal cell carcinoma: a multicenter phase II trial. Groupe Français d'Immunothérapie.
J Clin Oncol
; 16(8): 2728-32, 1998 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-9704724
18.
Multicentre phase II and pharmacokinetic study of RFS2000 (9-nitro-camptothecin) administered orally 5 days a week in patients with glioblastoma multiforme.
Eur J Cancer
; 38(10): 1348-50, 2002 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-12091065
19.
Patient preference for either the EORTC QLQ-C30 or the FACIT Quality Of Life (QOL) measures: a study performed in patients suffering from carcinoma of an unknown primary site (CUP).
Eur J Cancer
; 40(4): 521-8, 2004 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-14962718
20.
Multicentre, phase II study evaluating capecitabine monotherapy in patients with anthracycline- and taxane-pretreated metastatic breast cancer.
Eur J Cancer
; 40(4): 536-42, 2004 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-14962720